Philip Powell

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · New England Journal of Medicine · 2016 · 2.6K citations · Full text

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · New England Journal of Medicine · 2023 · 665 citations · Full text

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Samantha Cambier, Richard Sylvester, Laurence Collette et al. · European Urology · 2015 · 616 citations · Full text

Eortc Nomograms, Prognostic Biomarkers, Urology +10

A PROSPECTIVE ANALYSIS OF 1,930 PATIENTS WITH HEMATURIA TO EVALUATE CURRENT DIAGNOSTIC PRACTICE

Mohamed Khadra, R.S. Pickard, Martin Charlton et al. · The Journal of Urology · 2000 · 443 citations

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard Sylvester, Maurizio Brausi, Wim J. Kirkels et al. · European Urology · 2009 · 426 citations · Full text

Urological Research, Urology, Bacillus Calmette-guérin +9